UBS Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.1M Sell
89,100
-101,200
-53% -$51.2M 0.01% 1844
2025
Q4
$108M Buy
190,300
+92,800
+95% +$49.4M 0.02% 975
2025
Q3
$43.6M Sell
97,500
-26,900
-22% -$12.9M 0.01% 1776
2025
Q2
$67.6M Sell
124,400
-5,700
-4% -$2.98M 0.01% 1255
2025
Q1
$64.4M Buy
130,100
+32,300
+33% +$17.9M 0.01% 1249
2024
Q4
$51M Buy
97,800
+36,100
+59% +$18.8M 0.01% 1442
2024
Q3
$30.3M Buy
61,700
+58,300
+1,715% +$27.1M 0.01% 1515
2024
Q2
$1.51M Sell
3,400
-99,100
-97% -$39.5M ﹤0.01% 4041
2024
Q1
$40.9M Sell
102,500
-9,600
-9% -$3.63M 0.01% 1166
2023
Q4
$37.8M Sell
112,100
-8,000
-7% -$2.38M 0.01% 1144
2023
Q3
$35.1M Buy
120,100
+24,500
+26% +$7.65M 0.01% 1065
2023
Q2
$32.7M Sell
95,600
-16,500
-15% -$4.99M 0.01% 1086
2023
Q1
$28.6M Sell
112,100
-6,909
-6% -$1.7M 0.01% 1132
2022
Q4
$31.6M Buy
119,009
+809
+0.7% +$197K 0.01% 1107
2022
Q3
$22.2M Buy
118,200
+10,100
+9% +$2.17M 0.01% 1204
2022
Q2
$21.7M Buy
108,100
+77,500
+253% +$18.2M 0.01% 1253
2022
Q1
$9.23M Sell
30,600
-146,230
-83% -$42.7M ﹤0.01% 2002
2021
Q4
$63.5M Buy
176,830
+9,841
+6% +$3.39M 0.02% 810
2021
Q3
$55.3M Sell
166,989
-12,300
-7% -$4.13M 0.02% 813
2021
Q2
$55M Buy
179,289
+65,400
+57% +$18.3M 0.02% 805
2021
Q1
$28.1M Sell
113,889
-5,211
-4% -$1.31M 0.01% 1205
2020
Q4
$32.5M Buy
119,100
+18,000
+18% +$4.47M 0.01% 1035
2020
Q3
$23.9M Buy
101,100
+80,100
+381% +$18M 0.01% 1054
2020
Q2
$3.99M Sell
21,000
-22,500
-52% -$4.03M ﹤0.01% 2227
2020
Q1
$7.18M Buy
43,500
+3,000
+7% +$549K ﹤0.01% 1636
2019
Q4
$7.98M Sell
40,500
-30,000
-43% -$5.62M ﹤0.01% 2154
2019
Q3
$12.7M Sell
70,500
-27,000
-28% -$4.67M ﹤0.01% 1576
2019
Q2
$17M Buy
+97,500
New +$16.7M 0.01% 1323
2019
Q1
Sell
-39,000
Closed -$6.23M 7920
2018
Q4
$6.23M Sell
39,000
-1,200
-3% -$203K ﹤0.01% 1969
2018
Q3
$7.69M Sell
40,200
-19,200
-32% -$3.41M ﹤0.01% 1989
2018
Q2
$9.47M Hold
59,400
﹤0.01% 1808
2018
Q1
$8.17M Sell
59,400
-342,900
-85% -$47.9M ﹤0.01% 1872
2017
Q4
$48.9M Buy
402,300
+36,000
+10% +$4.51M 0.02% 684
2017
Q3
$42.6M Buy
366,300
+27,000
+8% +$2.94M 0.02% 678
2017
Q2
$35.3M Sell
339,300
-156,600
-32% -$15.1M 0.02% 736
2017
Q1
$42.2M Buy
495,900
+207,000
+72% +$16.4M 0.02% 614
2016
Q4
$20.4M Buy
288,900
+225,000
+352% +$16.5M 0.01% 1013
2016
Q3
$5.15M Sell
63,900
-72,000
-53% -$5.51M ﹤0.01% 1993
2016
Q2
$9.99M Buy
135,900
+72,000
+113% +$5.07M 0.01% 1384
2016
Q1
$4.27M Sell
63,900
-80,100
-56% -$4.96M ﹤0.01% 2008
2015
Q4
$8.74M Sell
144,000
-6,300
-4% -$354K 0.01% 1494
2015
Q3
$7.67M Hold
150,300
0.01% 1590
2015
Q2
$8.09M Buy
150,300
+144,900
+2,683% +$8.11M 0.01% 1636
2015
Q1
$303K Sell
5,400
-12,600
-70% -$713K ﹤0.01% 4547
2014
Q4
$1.06M Buy
+18,000
New +$1M ﹤0.01% 3525

Other funds holding ISRG

UBS Group's ISRG Position: Q1 2026 in Review

UBS Group reduced its Intuitive Surgical (ISRG) stake by 10% in Q1 2026, selling an estimated $93M and leaving 1,637,924 shares worth $755M. The position accounts for 0.11% of the portfolio, ranked #174.

UBS Group first reported a position in ISRG in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.13B in Q4 2024. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • UBS Group held 1,637,924 shares of Intuitive Surgical worth $755M as of Q1 2026.
  • UBS Group sold 183,794 Intuitive Surgical shares in Q1 2026, an estimated $93M.
  • Intuitive Surgical made up 0.11% of UBS Group's portfolio in Q1 2026, its #174 holding.
  • UBS Group first reported a position in Intuitive Surgical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Intuitive Surgical position peaked at $1.13B in Q4 2024.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.